ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.
Phase 4
Completed
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2010-11-30
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 277
- Registration Number
- NCT00246168
Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
Phase 4
Completed
- Conditions
- Epilepsy, Rolandic
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-02-01
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 114
- Registration Number
- NCT00216567
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
Phase 4
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 527
- Registration Number
- NCT00216528
The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
Phase 4
Completed
- Conditions
- Alzheimer Disease
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 102
- Registration Number
- NCT00216515
The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania
Phase 4
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 118
- Registration Number
- NCT00216554
© Copyright 2025. All Rights Reserved by MedPath